selected publications
- Bidirectional regulation of motor circuits using magnetogenetic gene therapy. Science advances. 2024 Academic Article GET IT
- Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy. Frontiers in aging neuroscience. 2023 Academic Article GET IT
- State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson's disease: What meta-analysis studies cannot tell us. Frontiers in aging neuroscience. 2022 Review GET IT
- Angiotensin II differentially affects hippocampal glial inflammatory markers in young adult male and female mice. Learning & memory (Cold Spring Harbor, N.Y.). 2022 Academic Article GET IT
- Mapping and targeted viral activation of pancreatic nerves in mice reveal their roles in the regulation of glucose metabolism. Nature biomedical engineering. 2022 Academic Article GET IT
-
Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer's and Parkinson's Disease Patients.
Dementia and geriatric cognitive disorders.
2021
Academic Article
GET IT
Times cited: 5 - Specific Mapping and modulation of pancreatic innervation to regulate glucose metabolism using targeted viral vector strategies. Nature Biomedical Engineering. 2021 Academic Article
- Specific Mapping and modulation of pancreatic innervation to regulate glucose metabolism using targeted viral vector strategies. 2021 Article
- p11 Gene Therapy as a Novel Target for Treatment of Symptoms and Medication Complications in Parkinson’s Disease. Gene Therapy in Neurological Disorders. 2018 Chapter
-
Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.
Brain research.
2017
Academic Article
GET IT
Times cited: 31 -
Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.
Proceedings of the National Academy of Sciences of the United States of America.
2016
Academic Article
GET IT
Times cited: 20 -
p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism.
Proceedings of the National Academy of Sciences of the United States of America.
2016
Academic Article
GET IT
Times cited: 12 -
Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling.
Journal of neuro-oncology.
2014
Academic Article
GET IT
Times cited: 19 -
Cell-type specific expression of p11 controls cocaine reward.
Biological psychiatry.
2014
Academic Article
GET IT
Times cited: 28 -
A subcellular analysis of genetic modulation of PINK1 on mitochondrial alterations, autophagy and cell death.
Archives italiennes de biologie.
2012
Academic Article
GET IT
Times cited: 33 -
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy.
Cell death and differentiation.
2010
Academic Article
GET IT
Times cited: 200 -
Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.
Journal of neurochemistry.
2009
Academic Article
GET IT
Times cited: 136 -
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum.
Human mutation.
2008
Academic Article
GET IT
Times cited: 62 -
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society.
2006
Academic Article
GET IT
Times cited: 21 -
PINK1 mutations are associated with sporadic early-onset parkinsonism.
Annals of neurology.
2004
Academic Article
GET IT
Times cited: 377